why choose us

First received: January 26, 2023

Clinical Trial: ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2, Open-Label, Multi-Center Study of ZN-c3 Administered in Combination With Encorafenib and Cetuximab in Adults With Metastatic Colorectal Cancer

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and potential clinical benefits of ZN-c3 administered in combination with encorafenib and cetuximab in adult participants with metastatic BRAF V600E mutant colorectal cancer previously treated with one or two treatment regimens.

Read more